Insider Buying: Cardiol Therapeutics Inc. (TSE:CRDL) Senior Officer Purchases 10,000 Shares of Stock December 18, 2024 by InsiderTrades.com Share Cardiol Therapeutics Inc. (TSE:CRDL - Get Free Report) Senior Officer Bernard Lim purchased 10,000 shares of the company's stock in a transaction that occurred on Tuesday, December 17th. The stock was bought at an average price of C$1.95 per share, with a total value of C$19,500.00. Cardiol Therapeutics Price PerformanceShares of CRDL stock opened at C$1.95 on Wednesday. The firm has a fifty day moving average of C$2.41 and a two-hundred day moving average of C$2.73. The firm has a market cap of C$136.27 million, a P/E ratio of -4.43 and a beta of 0.70. Cardiol Therapeutics Inc. has a 1-year low of C$1.07 and a 1-year high of C$4.26. The company has a debt-to-equity ratio of 1.07, a current ratio of 2.39 and a quick ratio of 6.84. Cardiol Therapeutics Company Profile (Get Free Report)Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis.See AlsoFive stocks we like better than Cardiol TherapeuticsWhat Are Growth Stocks and Investing in Them AppLovin Insiders Sell Shares: Stock Price Indicated Higher What Is WallStreetBets and What Stocks Are They Targeting?Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector RallyWhen to Sell a Stock for Profit or LossSalesforce's Clear Path to $400 and BeyondThis instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected]. Insider Buying or Selling at Cardiol Therapeutics? Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Cardiol Therapeutics and related companies. More From MarketBeatTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | Sponsored7 Nuclear Energy Stocks to Buy on Growing DemandThe question isn't if nuclear energy is making a comeback, but why? There are several answers, starting with t...MarketBeatUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | Sponsored7 Best REITs to Buy as the Interest Rates FallEvery investor knows that certainty is hard to find. But it's relatively easy to find opportunities where mone...MarketBeatHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored7 Dividend Aristocrats to Buy After EarningsDuring earnings season, analysts talk about earnings growth — and for good reason. Nothing drives stock ...MarketBeatHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredThe Best Energy Stocks to Buy NowWith recent disruptions in the international energy markets, there has been a renewed attention on public ener...MarketBeat Free Insider Buying and Selling Newsletter Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report. From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Most Read This MonthAre 2024’s Top Insider Buys a Good Bet for 2025? AppLovin Insiders Sell Shares: Stock Price Indicated Higher Zeta Global Holdings Insiders Buy Stock After Short-ReportInsider Selling: SoFi Technologies, Inc. (NASDAQ:SOFI) Director Sells 52,000 Shares of StockInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidArcher Aviation Inc. (NYSE:ACHR) CEO Acquires $101,181.44 in StockJames William Kupiec Sells 4,000 Shares of Cassava Sciences, Inc. (NASDAQ:SAVA) StockRigetti Computing, Inc. (NASDAQ:RGTI) Director Michael S. Clifton Sells 125,000 SharesRecent ArticlesReWalk Robotics Ltd. (NASDAQ:LFWD) Director Acquires $10,140.00 in StockMonika U. Ehrman Purchases 180 Shares of Matador Resources (NYSE:MTDR) StockInsider Buying: Sun Summit Minerals Corp. (CVE:SMN) Director Purchases 100,000 Shares of StockCANEX Metals Inc. (CVE:CANX) Director Shane William Ebert Acquires 310,000 Shares of StockBarfresh Food Group, Inc. (NASDAQ:BRFH) CFO Sells $11,938.08 in StockTimothy Mattox Sells 2,768 Shares of Upland Software, Inc. (NASDAQ:UPLD) StockIrene Becklund Sells 472 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) StockCraig Wood William Acquires 1,475 Shares of Sylogist Ltd. (TSE:SYZ) Stock
